Fungal infections in bone marrow transplant patients
- PMID: 2353204
Fungal infections in bone marrow transplant patients
Abstract
In a retrospective study of over 1,500 patients who underwent bone marrow transplantation between 1980 and 1987, the incidence of invasive candidal or mold infection was 11% and 4.5%, respectively. Candidemia alone occurred in 46, candidemia and tissue infection in 56, and tissue infection alone in 69 of 1,510 patients analyzed. Aspergillus infection alone occurred in 69, other mold infections occurred in four, and Aspergillus plus other mold infections in two of 1,658 patients analyzed. Median time to onset of candidal infection was 2 weeks and of mold infections 6 weeks after transplantation. Overall mortality for patients with candidal infection was 73% and for those with Aspergillus or other mold infections, 84%. Death occurred in 39% of patients with candidemia alone, 90% of patients with candidal tissue infection with or without candidemia, and 100% of those with mixed infection. The death rate was 75% for patients infected with Aspergillus alone, 83% for those infected with other molds with or without Aspergillus, and 100% when there was coinfection with Candida or cytomegalovirus. The probability of occurrence of Aspergillus infection was influenced by patient age, donor match, type of conditioning regimen, and occurrence of acute graft-versus-host disease (GVHD), while the occurrence of candidal infection was influenced by additional factors including underlying disease and GVHD prophylactic regimen. In contrast to some published reports, the risk of Aspergillus infection was not significantly altered by infection prevention methods, including provision of a protective environment. These data confirm both the high incidence and severity of fungal infection after bone marrow transplantation and underscore the urgent need for more effective prophylaxis and treatment.
Similar articles
-
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.J Clin Oncol. 1994 Apr;12(4):827-34. doi: 10.1200/JCO.1994.12.4.827. J Clin Oncol. 1994. PMID: 8151325
-
Fungal infections in patients undergoing blood and marrow transplantation.Transpl Infect Dis. 1999 Dec;1(4):237-46. doi: 10.1034/j.1399-3062.1999.010403.x. Transpl Infect Dis. 1999. PMID: 11428995 Review.
-
Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.Bone Marrow Transplant. 2000 Nov;26(9):999-1004. doi: 10.1038/sj.bmt.1702654. Bone Marrow Transplant. 2000. PMID: 11100280
-
Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears.Clin Infect Dis. 1997 Jul;25(1):37-42. doi: 10.1086/514492. Clin Infect Dis. 1997. PMID: 9243031
-
Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.Bone Marrow Transplant. 1996 Nov;18 Suppl 2:97-106. Bone Marrow Transplant. 1996. PMID: 8932808 Review.
Cited by
-
Diagnostic options for pulmonary fungal diseases in Africa.ERJ Open Res. 2023 Apr 11;9(2):00397-2022. doi: 10.1183/23120541.00397-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37057083 Free PMC article.
-
Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.J Cancer Res Clin Oncol. 2017 Jul;143(7):1281-1292. doi: 10.1007/s00432-017-2369-7. Epub 2017 Mar 3. J Cancer Res Clin Oncol. 2017. PMID: 28258343 Clinical Trial.
-
Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.Virulence. 2016 Nov 16;7(8):901-916. doi: 10.1080/21505594.2016.1208866. Epub 2016 Jul 6. Virulence. 2016. PMID: 27385018 Free PMC article. Review.
-
An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.Virulence. 2015;6(4):376-84. doi: 10.1080/21505594.2015.1025192. Virulence. 2015. PMID: 26065322 Free PMC article.
-
Routine versus selective antifungal administration for control of fungal infections in patients with cancer.Cochrane Database Syst Rev. 2014 Sep 4;2014(9):CD000026. doi: 10.1002/14651858.CD000026.pub2. Cochrane Database Syst Rev. 2014. PMID: 25188768 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical